This study aimed to compare the functioning, symptoms, and quality of life (QoL) of patients with breast or colon cancer before and after their first-cycle (FC) chemotherapy.
Design:
One-group pretest/posttest design.
Method:
The study utilized the standardized Arabic-translated Quality of Life Questionnaire Version 3 from the European Organization for Research and Treatment of Cancer in measuring the functioning, symptoms, and QoL of 120 Saudi patients diagnosed with breast or colon cancer. Dependent t test was used in analyzing the presence of significant differences in mean scores before and after chemotherapy with periods ranging from 14 days to 21 days following the treatment protocol.
Results:
The findings revealed significant differences in the functioning, symptoms, and QoL among patients with breast or colon cancer before and after FC chemotherapy (p < .001). Baseline scores showed higher physical, role, emotional, cognitive, and social functioning; lesser symptoms; lower financial difficulties; and better overall global health status compared to post-FC chemotherapy.
Conclusion:
Assessing the QoL of patients with breast or colon cancer undergoing FC chemotherapy is essential to establish a holistic care plan in supporting and alleviating the unfavorable effects of chemotherapy and implement patient-centered interventions that aid in the enhancement of their overall QoL.
AaronsonN. K.AhmedzaiS.BergmanB.BullingerM.CullA.DuezN. J.FilibertiA.FlechtnerH.FleishmanS. B.de HaesJ. C. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. https://doi.org/10.1093/jnci/85.5.365
2.
AhidB.MarikP. E. (2008). Pulmonary complications of novel antineoplastic agents for solid tumors. Chest, 133(2), 528-538. https://doi.org/10.1378/chest.07-0851
AhmedA. E.AlmuzainiA. S.AlsadhanM. A.AlharbiA. G.AlmuzainiH. S.AliY. Z.JaziehA. R. (2018). Health-related predictors of quality of life in cancer patients in Saudi Arabia. Journal of Cancer Education, 33(5), 1011-1019. https://doi.org/10.1007/s13187-017-1198-3
5.
AltwairgiA. K.AlfakeehA. H.HopmanW. M.ParulekarW. R. (2015). Quality of reporting of chemotherapy compliance in randomized controlled trials of breast cancer treatment. Japanese Journal of Clinical Oncology, 45(6), 520-526. https://doi.org/10.1093/jjco/hyv043
BallatoriE. (2001). Unsolved problems in evaluating the quality of life of cancer patients. Annals of Oncology, 12(Suppl. 3), S11-S13. https://doi.org/10.1093/annonc/12.suppl_3.S11
8.
BatesJ. S.AutenJ.SketchM. R.PatelT.ClarkS. M.MorganK. P.MulunehB.McLaughlinJ. E.PinelliN. R.FosterM. C.AmerineL. (2019). Patient engagement in first cycle comprehensive chemotherapy consultation pharmacist services and impact on patient activation. Journal of Oncology Pharmacy Practice, 25(4), 896-902. https://doi.org/10.1177/1078155219832644
9.
BroomfieldS.CurrieA.van der MostR. G.BrownM.van BruggenI.RobinsonB. W.LakeR. A. (2005). Partial, but not complete, tumor-debulking surgery promotes protective antitumor memory when combined with chemotherapy and adjuvant immunotherapy. Cancer Research, 65(17), 7580-7584. https://doi.org/10.1158/0008-5472.CAN-05-0328
10.
CampbellJ. (2007). Understanding social support for patients with cancer. Nursing Times, 103(23), 28-29.
11.
ChaganiP.ParpioY.GulR.JabbarA. A. (2017). Quality of life and its determinants in adult cancer patients undergoing chemotherapy treatment in Pakistan. Asia-Pacific Journal of Oncology Nursing, 4(2), 140-146.
12.
CharalambousA.KaiteC. P.CharalambousM.TistsiT.KoutaC. (2017). The effects on anxiety and quality of life of breast cancer patients following completion of the first cycle of chemotherapy. SAGE Open Medicine, 5, 2050312117717507. https://doi.org/10.1177/2050312117717507
13.
CherrierM. M.AndersonK.DavidD.HiganoC. S.GrayH.ChurchA.WillisS. L. (2013). A randomized trial of cognitive rehabilitation in cancer survivors. Life Sciences, 93(17), 617-622. https://doi.org/10.1016/j.lfs.2013.08.011
14.
de JongN.CandelM. J.SchoutenH. C.Abu-SaadH. H.CourtensA. M. (2006). Course of the fatigue dimension “activity level” and the interference of fatigue with daily living activities for patients with breast cancer receiving adjuvant chemotherapy. Cancer Nursing, 29(5), E1-E13. https://doi.org/10.1097/00002820-200609000-00013
15.
EsbensenB. A.ØsterlindK.HallbergI. R. (2006). Quality of life of elderly persons with cancer: A 3-month follow-up. Cancer Nursing, 29(3), 214-224. https://doi.org/10.1097/00002820-200605000-00008
16.
FangelL. V.PanobiancoM. S.KebbeL. M.AlmeidaA. M.GozzoT. O. (2013). Quality of life and daily activities performance after breast cancer treatment. Acta Paulista de Enfermagem, 26, 93-100. https://doi.org/10.1590/S0103-21002013000100015
17.
FarberS.DiamondL. K.MercerR. D.SylvesterR. F.WolffJ. A. (1948). Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. New England Journal of Medicine, 238, 787-793. https://doi.org/10.1056/NEJM194806032382301
18.
FayersP.AaronsonN. K.BjordalK.GroenvoldM.CurranD.BottomleyA. (2001). EORTC QLQ-C30 scoring manual (3rd ed.). European Organisation for Research and Treatment of Cancer.
19.
FieldA. (2018). Discovering statistics using IBM SPSS statistics (5th ed.). Sage.
20.
GalmariniD.GalmariniC. M.GalmariniF. C. (2012). Cancer chemotherapy: A critical analysis of its 60 years of history. Critical Reviews in Oncology/Hematology, 84(2), 181-199. https://doi.org/10.1016/j.critrevonc.2012.03.002
21.
García-GarcíaT.Carmona-BayonasA.Jimenez-FonsecaP.JaraC.BeatoC.CasteloB.CalderónC. (2019). Biopsychosocial and clinical characteristics in patients with resected breast and colon cancer at the beginning and end of adjuvant treatment. BMC Cancer, 19, Article 1143. https://doi.org/10.1186/s12885-019-6358-x
22.
GerteisM.Edgman-LevitanS.DaleyJ.DelbancoT. L. (1993). Through the patient’s eyes: Understanding and promoting patient-centered care. Jossey-Bass.
23.
HoppeS.RainfrayM.FonckM.HoppenreysL.BlancJ. F.CeccaldiJ.MertensC.Blanc-BissonC.ImbertY.CanyL.VogtL.DaubaJ.HouédéN.BelleraC. A.FloquetA.FabryM. N.RavaudA.ChakibaC.Mathoulin-PélissierS.SoubeyranP. (2013). Functional decline in older patients with cancer receiving first-line chemotherapy. Journal of Clinical Oncology, 31(31), 3877-3882. https://doi.org/10.1200/JCO.2012.47.7430
24.
HsuH. T.LinK. C.WuL. M.JuanC. H.HouM. F.HwangS. L.LiuY.DoddM. J. (2017). Symptom cluster trajectories during chemotherapy in breast cancer outpatients. Journal of Pain and Symptom Management, 53(6), 1017-1025. https://doi.org/10.1016/j.jpainsymman.2016.12.354
25.
JassimG. A.WhitfordD. L. (2013). Quality of life of Bahraini women with breast cancer: A cross sectional study. BMC Cancer, 13, 212. https://doi.org/10.1186/1471-2407-13-212
26.
JemalA.BrayF.CenterM. M.FerlayJ.WardE.FormanD. (2011). Global cancer statistics. CA: A Cancer Journal for Clinicians, 61(2), 69-90. https://doi.org/10.3322/caac.20107
27.
LiC. C.ChenM. L.ChangT. C.ChouH. H.ChenM. Y. (2015). Social support buffers the effect of self-esteem on quality of life of early-stage cervical can survivors in Taiwan. European Journal of Oncology Nursing, 19(5), 486-494. https://doi.org/10.1016/j.ejon.2015.02.008
28.
LiJ. J. (2006). Laughing gas, Viagra, and Lipitor: The human stories behind the drugs we use. Oxford University Press.
29.
LiQ.XuY.ZhouH.LokeA. Y. (2016). Factors influencing the health-related quality of life of Chinese advanced cancer patients and their spousal caregivers: A cross-sectional study. BMC Palliative Care, 15, 72. https://doi.org/10.1186/s12904-016-0142-3
30.
LôboS. A.FernandesA. F. C.de AlmeidaP. C.CarvalhoC. M.SawadaN. O. (2014). Quality of life in women with breast cancer undergoing chemotherapy. Acta Paulista de Enfermagem, 27(6), 554-559. https://doi.org/10.1590/1982-0194201400090
MarventanoS.ForjazM.GrossoG.MistrettaA.GiorgianniG.PlataniaA.GangiS.BasileF.BiondiA. (2013). Health related quality of life in colorectal cancer patients: State of the art. BMC Surgery, 13(Suppl. 2), S15. https://doi.org/10.1186/1471-2482-13-S2-S15
33.
McDonaldB. C.SaykinA. J. (2013). Alterations in brain structure related to breast cancer and its treatment: Chemotherapy and other considerations. Brain Imaging and Behavior, 7(4), 374-387. https://doi.org/10.1007/s11682-013-9256-x
34.
MontazeriA. (2008). Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007. Journal of Experimental & Clinical Cancer Research, 27(1), 32. https://doi.org/10.1186/1756-9966-27-32
35.
MontazeriA.VahdaniniaM.HarirchiI.EbrahimiM.KhaleghiF.JarvandiS. (2008). Quality of life in patients with breast cancer before and after diagnosis: An eighteen months follow-up study. BMC Cancer, 8, 330. https://doi.org/10.1186/1471-2407-8-330
36.
MosconiP.ApoloneG.BarniS.SecondinoS.SbanottoA.FilibertiA. (2002). Quality of life in breast and colon cancer long-term survivors: An assessment with the Eortc Qlq-c30 and Sf-36 questionnaires. Tumori Journal, 88(2), 110-116.
37.
MyersJ. S. (2012). Chemotherapy-related cognitive impairment: The breast cancer experience. Oncology Nursing Forum, 39, E31-E40.
38.
MystakidouK.TsilikaE.ParpaE.KalaidopoulouO.SmyrniotisV.VlahosL. (2001). The EORTC core quality of life questionnaire (QLQ-C30, Version 3.0) In terminally ill cancer patients under palliative care: Validity and reliability in a hellenic sample. International Journal of Cancer, 94(1), 135-139. https://doi.org/10.1002/ijc.1439
39.
S. E.Otto (Ed.). (2001). Chemotherapy: Oncology nursing (SEOtto ed.). Harcourt Health Sciences.
40.
ParkS. B.KrishnanA. V.LinC. S.GoldsteinD.FriedlanderM.KiernanM. C. (2008). Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies. Current Medicinal Chemistry, 15(29), 3081-3094. https://doi.org/10.2174/092986708786848569
41.
PerboniS.BowersC.KojimaS.AsakawaA.InuiA. (2008). Peptide 2 reverses anorexia associated with chemotherapy with 5-fluoruracil in Growth hormone releasing colon cancer cell-bearing mice. World Journal of Gastroenterology, 14(41), 6303-6305. https://doi.org/10.3748/wjg.14.6303
42.
RhaS. Y.LeeJ. (2017). Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life. Supportive Care in Cancer, 25(5), 1519-1527. https://doi.org/10.1007/s00520-016-3545-z
43.
SahayT. B.GrayR. E.FitchM. (2000). A qualitative study of patient perspectives on colorectal cancer. Cancer Practice, 13(1), 38-44. doi10.1046/j.1523-5394.2000.81012.x
44.
SasakiH.TamuraK.NaitoY.OgataK.MogiA.TanakaT.IkariY.MasakiM.NakashimaY.TakamatsuY. (2017). Patient perceptions of symptoms and concerns during cancer chemotherapy: “Affects my family” is the most important. International Journal of Clinical Oncology, 22(4), 793-800. https://doi.org/10.1007/s10147-017-1117-y
SaykinA. J.AhlesT. A.McDonaldB. C. (2003). Mechanisms of chemotherapy-induced cognitive disorders: Neuropsychological, pathophysiological and neuroimaging perspectives. Seminars in Clinical Neuropsychiatry, 8(4), 201-216.
47.
SaykinA. J.de RuiterM. B.McDonaldB. C.DeprezS.SilvermanD. H. (2013). Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: Current status and recommendations for future research. Brain Imaging and Behavior, 7(4), 363-373.
48.
SmithL. C.BertolottiP.CurranK.JenkinsB. (2008). Gastrointestinal side effects associated with novel therapies in patients with multiple myeloma: Consensus statement of the IMF Nurse Leadership Board. Clininical Journal of Oncology Nursing, 12(3), 37-52. https://doi.org/10.1188/08.CJON.S1.37-51
49.
TabataA.KanaiM.HorimatsuT.TsuboyamaT.MatsushimaK.KatoT. (2018). Changes in upper extremity function, ADL, and HRQoL in colorectal cancer patients after the first chemotherapy cycle with oxaliplatin: A prospective single-center observational study. Supportive Care in Cancer, 26(7), 2397-2405. https://doi.org/10.1007/s00520-018-4070-z
50.
ÜstündağS.ZencirciA. D. (2015). Factors affecting the quality of life of cancer patients undergoing chemotherapy: A questionnaire study. Asia-Pacific Journal of Oncology Nursing, 2(1), 17-25. https://doi.org/10.4103/2347-5625.152402
51.
Van CutsemE.ArendsJ. (2005). The causes and consequences of cancer-associated malnutrition. European Journal of Oncology Nursing, 9(Suppl. 2), S51-S63. https://doi.org/10.1016/j.ejon.2005.09.007
52.
Von AhD.HabermannB.CarpenterJ. S.SchneiderB. L. (2013). Impact of perceived cognitive impairment in breast cancer survivors. European Journal of Oncology Nursing, 17(2), 236-241. https://doi.org/10.1016/j.ejon.2012.06.002
53.
von ElmE.AltmanD. G.EggerM.PocockS. J.GøtzscheP. C.VandenbrouckeJ. P. (2008). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Journal of Clinical Epidemiology, 61(4), 344-349. https://doi.org/10.1016/j.jclinepi.2007.11.008
54.
WeisseA. B. (1991). Medical odysseys: The different and sometimes unexpected pathways to twentieth-century medical discoveries. Rutgers University Press.
